Washington University in St. Louis / Dennis E. Hallahan*
Abstract
Purpose:
Non-small cell lung cancer (NSCLC) and glioblastoma multiforme (GBM) have poor median survival. NSCLC and GBM overexpress glucose regulated protein 78 (GRP78), which has a role in radioresistance and recurrence. In this study, we determined the effect of anti-GRP78 antibody and the combined effect of the anti-GRP78 antibody with ionizing radiation (XRT) on NSCLC and GBM cell lines both in vitro and in vivo
Experimental Design:
NSCLC and GBM cancer cell lines were treated with anti-GRP78 antibodies and evaluated for proliferation, colony formation, cell death, and PI3K/Akt/mTOR signaling. The efficacy of anti-GRP78 antibodies on tumor growth in combination with XRT was determined in vivo in mouse xenograft models.
Results:
GBM and NSCLC cells treated with anti-GRP78 antibodies showed attenuated cell proliferation, colony formation, and enhanced apoptosis. GBM and NSCLC cells treated with anti-GRP78 antibodies also showed global suppression of PI3K/Akt/mTOR signaling. Combining antibody with XRT resulted in significant tumor growth delay in both NSCLC and GBM heterotopic tumor models.
Conclusions:
Antibodies targeting GRP78 exhibited antitumor activity and enhanced the efficacy of radiation in NSCLC and GBM both in vitro and in vivo GRP78 is a promising novel target, and anti-GRP78 antibodies could be used as an effective cancer therapy alone or in combination with XRT.
Author information
Dadey DYA1,2, Kapoor V1, Hoye K3, Khudanyan A1, Collins A1, Thotala D4,5, Hallahan DE4,6,5.
1 Department of Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri.
2 Medical Scientist Training Program, Washington University in St. Louis, St. Louis, Missouri.
3 Medical Guidance Systems, St. Louis, Missouri.
4 Department of Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri. dhallahan@wustl.edu dthotala@wustl.edu.
5 Siteman Cancer Center, School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
6 Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri.